bpc-157 randomized clinical trial human Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights The Stable Gastric Pentadecapeptide BPC
Description
Daily Use: Twice daily (morning & night) on clean, dry skin
Other co-existing medical conditions might also be exclusion criteria, determined on a case-by-case risk-benefit assessment
Diet strategy Caloric deficit is mandatory
Users must maintain sterile technique throughout the process
Thyroid axis changes Rapid weight loss consistently affects the hypothalamic-pituitary-thyroid axis
